x
ServiziMenu principaleHome
You are here: Home > Events > Future Events > Residential Course - Clinical Oncology: Head & Neck Cancers
Print

Description

Scientific Coordinator: L. Licitra, IT


This residential course on head and neck cancers is addressed to an International audience of clinical oncologists interested in advancing their knowledge and skills on the clinical management of these tumors in a multidisciplinary context.
Taking into account that “networking” is the keyword to improve quality of care of rare cancers, the course is developed in the framework of EURACAN , the European Reference Network on rare adult solid cancers, with the aim of reinforcing the collaboration among oncologists of different countries who are already part of the network or willing to be part of it in the near future.
Attendance is limited to 30 participants and the admission will be on competitive application only.

LEARNING OBJECTIVES
To provide an overview of current multidisciplinary state-of-the-art treatment of head and neck cancers
To discuss relevant clinical cases on a multidisciplinary basis
To establish connections for future distance clinical mentoring/tutoring/networking

 

The residential course on head and neck
cancers is an ESO - EURACAN joint initiative
 
In the framework of  
Held in collaboration with   INT

 

Faculty

INVITED FACULTY
S. Alfieri, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
P. Bossi, Medical Oncology, University of Brescia, IT
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
C. Fallai, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
J.G. Eriksen, Aarhus University Hospital, Aarhus, DK
G. Gatta
, Fondazione IRCCS Istituto Nazionale Tumori, Milano IT

C . Gavazzi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
V. Gregoire, Universitè Catholique, Louvain, BE
A. Iacovelli, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
A.D. Jensen, Dept. Radiation Oncology, Heidelberg Univ. Hospital, Heidelberg, DE
L. Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Locati, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
P. Morbini, Department of Pathology, University of Pavia, IT
P. Nicolai,  ASST Spedali Civili,  Brescia, IT
E. Orlandi, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
C. Piazza, Fondazione IRCCS Istituto Nazionale Tumori, Milano, IT
L. Preda, Istituto Europeo di Oncologia, Milano, IT
A. Schindler, Department of Clinical and Biomedical Sciences, University of Milan, IT
C. Simon, Université de Lausanne, CHUV Lausanne, CH
A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milano IT

General information

ORGANISING SECRETARIAT
European School of Oncology
Rare Tumours Programme
Marina Fregonese
email: mfregonese@eso.net
phone: +39 02 23902106

ACCREDITATION
Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME) and to the Italian CME accreditation system.
EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the organising Secretariat.

OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.

VENUE
Villa Verganti Veronesi
Viale Lombardia 33
20010 Inveruno
Italia



HOW TO REACH THE VENUE





Application

PARTICIPANT'S PROFILE
• Medical degree
• Current involvement in clinical activities in oncology
• Fluency in English

HOW TO APPLY
Interested oncologists should apply online (at the top of this page) providing:
• Letter describing motivation for attending;
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)

Priority will be given to younger candidates and low/middle income countries.

ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY FOR A MAXIMUM OF 30 PARTICIPANTS.

Successful applicants are granted free registration. Travel and accommodation will not be covered and must be organized by participants.
APPLICATION DEADLINE: 28 FEBRUARY 2019

Before you start completing the online application form, please be sure you have all the requested files (CV and Motivation letter ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

Programme

1 April

INTRODUCTION
8:30   Registration
9:00   Introduction - The natural history and biology
L. Licitra, IT - L. Locati, IT
10:00   The epidemiology
G. Gatta, IT
11:00   Imaging
L. Preda, IT
12:00   The pathology
P. Morbini, IT
    Lunch
ORAL CAVITY (OC) AND OROPHARYNGEAL CANCER (OPC)
14:00   Surgery of OC
C. Simon, CH
15:00   Radiation of OC
J.G. Eriksen, DK
16:00   HPV and OPC
L. Licitra, IT

 2 April

9:00   Principles of treatment of OPC
V. Gregoire, FR
10:00   Transoral surgery of OPC
C. Piazza, IT
11:00   Radiation treatment of OPC
J.G. Eriksen, DK
12:00   Medical therapy of recurrent and metastatic disease
L. Locati, IT
    Lunch
CANCERS OF LARYNX AND HYPOPHARYNX
14:00   Surgery in early and advanced stage disease
C. Piazza, IT
15:00   Radiation in early and advanced stage disease
C. Fallai, IT
16:00   Principles of organ preservation
L. Licitra, IT

 3 April

9:00   Rehabilitation
A. Schindler, IT
10:00   Supportive care and nutrition in the curative setting
S. Alfieri, IT - C . Gavazzi, IT
11.00   Salvage surgery
C. Piazza, IT
12:00   Re-irradiation
C. Falla, IT
    Lunch
RARE CANCERS OF THE HEAD AND NECK
14:00   Nasopharyngeal cancer
E. Orlandi, IT
15:00   Surgery in nasal cavity and paranasal cancers
P. Nicolai, IT
16:00   Radiation therapy in nasal cavity and paranasal cancers
A. Iacovelli, IT
17:00   Hadron therapy in nasal and paranasal sinus cancers
A. Jensen, DK

4 April

9:00   Multimodality treatment in nasal cavity and paranasal sinus cancers
P. Bossi, IT
10:00   Salivary gland cancers
L. Locati, IT
11:00   The problems of multidisciplinarity
L. Licitra, IT
12:00   The problems of rare cancers and the EU initiatives
P.G. Casali, IT - A. Trama, IT
13:00   End of the course/closing remarks
L. Licitra, IT

 

Follow us